Cargando…
Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
Contraceptive implants provide long-acting, highly effective reversible contraception. The etonogestrel implant (ENG implant) is a single rod implant that offers three years of efficacy. The ENG implant was designed to provide contraceptive efficacy by inhibiting ovulation and Pearl Index scores rep...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778430/ https://www.ncbi.nlm.nih.gov/pubmed/19936163 |
_version_ | 1782174245833408512 |
---|---|
author | Hohmann, Heather |
author_facet | Hohmann, Heather |
author_sort | Hohmann, Heather |
collection | PubMed |
description | Contraceptive implants provide long-acting, highly effective reversible contraception. The etonogestrel implant (ENG implant) is a single rod implant that offers three years of efficacy. The ENG implant was designed to provide contraceptive efficacy by inhibiting ovulation and Pearl Index scores reported for this method are similar to other long-acting reversible contraception as well as similar to sterilization. The implant has been shown to be safe during breast feeding and may improve symptoms of dysmenorrhea and endometriosis. Irregular bleeding patterns can be expected with the device’s use and should be addressed in order to decrease rates of discontinuation. |
format | Text |
id | pubmed-2778430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27784302009-11-23 Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive Hohmann, Heather Patient Prefer Adherence Review Contraceptive implants provide long-acting, highly effective reversible contraception. The etonogestrel implant (ENG implant) is a single rod implant that offers three years of efficacy. The ENG implant was designed to provide contraceptive efficacy by inhibiting ovulation and Pearl Index scores reported for this method are similar to other long-acting reversible contraception as well as similar to sterilization. The implant has been shown to be safe during breast feeding and may improve symptoms of dysmenorrhea and endometriosis. Irregular bleeding patterns can be expected with the device’s use and should be addressed in order to decrease rates of discontinuation. Dove Medical Press 2009-11-03 /pmc/articles/PMC2778430/ /pubmed/19936163 Text en © 2009 Hohmann, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Hohmann, Heather Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive |
title | Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive |
title_full | Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive |
title_fullStr | Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive |
title_full_unstemmed | Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive |
title_short | Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive |
title_sort | examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778430/ https://www.ncbi.nlm.nih.gov/pubmed/19936163 |
work_keys_str_mv | AT hohmannheather examiningtheefficacysafetyandpatientacceptabilityoftheetonogestrelimplantablecontraceptive |